UNSPSC 51123602: Dronedarone

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) JQZ1L091Y2. European Medicines Agency schedules Dronedarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06408MIG. Dronedarone generally arises in the molecular formula C31H44N2O5S.

The term DRONEDARONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 11, No. 11997, list 37.) Most nations, for tariff and trade purposes, schedule dronedarone under HS 29350090 and SITC 51580. As of Q4 2014, DRONEDARONE remains US FDA's Preferred Term for this commodity. Dronedarone bears US NLM identifiers UMLS ID C0766326 and NCI Concept Code C65485. SMILES: S(=O)(=O)(NC1CC2C(C(OC2CC1)CCCC)C(=O)C1CCC(OCCCN(CCCC)CCCC)CC1)C.

UNSPSC 51123602 Dronedarone, a Commodity code, encompasses prescription and specialty medications supplied to state and local emergency response, public health, and social service agencies. State and local governments actually purchasing under this code procure advanced life support medications, generic pharmaceuticals, and over-the-counter products for fire rescue services, health departments, and multi-state cooperative purchasing programs. The issuing bodies soliciting under the code span city fire and rescue departments, state health and human services agencies, and regional cooperative purchasing alliances serving multiple states and local jurisdictions. Recent activity shows city-level procurement through traditional sealed-bid processes alongside state-level initiatives through cooperative purchasing vehicles and exploratory market-intelligence mechanisms.

Geographic activity is concentrated in Florida and the upper Midwest, with Texas emerging as a strategic market. The City of Tampa's Purchasing Department issued IFB No. 26P00188 in April 2026 for Advanced Life Support Medications—including Labetalol, Epinephrine, Adenosine, and Diltiazem vials totaling an estimated $40,000 for Tampa Fire Rescue, with bids due April 8, 2026, and a one-year contract term with options to renew. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026, and July 1, 2026 contract effectiveness. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program, signaling future procurement activity in prescription fulfillment and state pharmacy benefit management. City procurement generally emphasizes immediate delivery and strict expiration-date management; state and cooperative vehicles prioritize pricing competitiveness and multi-location distribution through authorized wholesaler networks.